These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 7685150)
1. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150 [TBL] [Abstract][Full Text] [Related]
2. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317 [TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Dervan PA; Magee HM; Buckley C; Carney DN Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598 [TBL] [Abstract][Full Text] [Related]
7. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Cartun RW; Coles FB; Pastuszak WT Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020 [TBL] [Abstract][Full Text] [Related]
8. [Determination of proliferation activity of prostate cancers by means of nuclear proliferation-associated formalin resistant Ki-S5 antigens]. Rudolph P; Lappe T; Kreipe H; Parwaresch MR; Schmidt D Verh Dtsch Ges Pathol; 1993; 77():98-102. PubMed ID: 7511311 [TBL] [Abstract][Full Text] [Related]
9. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [TBL] [Abstract][Full Text] [Related]
10. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843 [TBL] [Abstract][Full Text] [Related]
11. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies. Wang PL; Peh SC Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related]
13. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies. Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572 [TBL] [Abstract][Full Text] [Related]
14. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas. Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue. Linder J; Ye Y; Armitage JO; Weisenburger DD Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335 [TBL] [Abstract][Full Text] [Related]
17. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607 [TBL] [Abstract][Full Text] [Related]
18. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia]. Ito M; Tsurusawa M; Kawai S; Fujimoto T Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840 [TBL] [Abstract][Full Text] [Related]
20. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Kreipe H; Heidebrecht HJ; Hansen S; Röhlk W; Kubbies M; Wacker HH; Tiemann M; Radzun HJ; Parwaresch R Am J Pathol; 1993 Jan; 142(1):3-9. PubMed ID: 8093827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]